Please provide your email address to receive an email when new articles are posted on . There has been quite an evolution of IOLs since their inception. In the era of refractive cataract surgery, ...

Please provide your email address to receive an email when new articles are posted on . Ophthalmologists have been searching for effective ways to address presbyopia for many decades, particularly ...

Advanced technology lenses work best in pristine eyes. Problems with ocular alignment, pupil size, ocular surface disease, ...

Dec. 12, 2003 — Editor's Note: On Nov. 14, Eyeonics, Inc., received U.S. Food and Drug Administration (FDA) approval to market the first accommodating intraocular lens (Crystalens) that allows ...

Bausch & Lomb has introduced Crystalens AO, an aberration free accommodating intraocular lens with aspheric optics, according to a Bausch & Lomb news release. The Crystalens AO has prolate aspheric ...

PowerVision, Inc., a private company developing an accommodating intraocular lens, today announced the closing of the first tranche of its Series D funding round with participation from existing ...

LensGen, a California-based developer of intraocular lenses (IOL) for the treatment of presbyopia and cataracts, has announced the release of $11 million in Series A funding. The funds are part of the ...

New types of intraocular lens, femtosecond laser, collagen cross-linking, and microinvasive glaucoma surgery (MIGS) will feature prominently at the upcoming American Society of Cataract and Refractive ...

IRVINE, Calif.--(BUSINESS WIRE)--April 12, 2004--Medennium Inc. of Irvine, a leader in innovative solutions for ophthalmology, announced today that it has retained GD Services Inc. of Newport Beach, ...

Abbott, based in Abbott Park, Ill., acquired Irvine, Calif.-based Visiogen for $400 million in cash, expanding the company’s vision care portfolio, according to an Abbott news release. As part of the ...

Abbott, based in Abbott Park, Ill., acquired Irvine, Calif.-based Visiogen for $400 million in cash, expanding the company's vision care portfolio, according to an Abbott news release. As part of the ...